Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial
Trials. 2019 Jun 20;20(1):368.
doi: 10.1186/s13063-019-3519-9.
1 Department of Anesthesia and Pain Medicine, Erasmus MC-Sophia Children's Hospital, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. t.deleeuw@erasmusmc.nl.
2 Consorzio per Valutazione Biologiche e Farmacologiche, Pavia, Italy.
3 Fondazione Penta Onlus, Padova, Italy.
4 Department of Pediatric Pharmacology and Pharmacogenetics, AP-HP, Hôpital Robert Debré, F-75019, Paris, France.
5 Inserm, CIC 1426, F-75019, Paris, France.
6 Université Paris Diderot, Sorbonne Paris Cité, EA 08, F-75010, Paris, France.
7 Intensive Care and Department of Paediatric Surgery, Erasmus MC-Sophia Children's Hospital, Dr. Molewaterplein, 40 3015 GD, Rotterdam, The Netherlands.
8 University College London, London, UK.
9 Department of Pharmacology and Toxicology, Radboud University, Nijmegen, The Netherlands.
Following publication of the original article [1], we have been notified that the tagging of one of the author names was done incorrectly in the XML version of the paper. Original and corrected tagging can be seen below.